107 related articles for article (PubMed ID: 2134016)
1. Recombinant DNA virus vectors for vaccination.
Moss B
Semin Immunol; 1990 Sep; 2(5):317-27. PubMed ID: 2134016
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vectors as vaccines and immunotherapeutics.
Jolly DJ; Warner JF
Semin Immunol; 1990 Sep; 2(5):329-39. PubMed ID: 1966858
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
4. Recombinant virus vaccines--present status and future prospects.
Heinrich HW
Arch Exp Veterinarmed; 1990; 44(6):849-53. PubMed ID: 2102650
[TBL] [Abstract][Full Text] [Related]
5. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
6. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
7. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
Taylor J; Paoletti E
Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
9. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
[TBL] [Abstract][Full Text] [Related]
10. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
11. Poxvirus-based vectors as vaccine candidates.
Tartaglia J; Pincus S; Paoletti E
Crit Rev Immunol; 1990; 10(1):13-30. PubMed ID: 2407263
[TBL] [Abstract][Full Text] [Related]
12. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
14. Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by an adenovirus vector with an inducible promoter.
Elahi SM; Shen SH; Talbot BG; Massie B; Harpin S; Elazhary Y
Virology; 1999 Aug; 261(1):1-7. PubMed ID: 10441551
[TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant BCG bearing Schistosoma japonicum 26Ku antigen gene and study on its immunogenicity on mice].
Dai W; Huangfu Y; Zheng B
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):407-10. PubMed ID: 11798793
[TBL] [Abstract][Full Text] [Related]
16. Rational design of gene-based vaccines.
Barouch DH
J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
[TBL] [Abstract][Full Text] [Related]
17. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
18. Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles.
Bereta M; Bereta J; Park J; Medina F; Kwak H; Kaufman HL
Cancer Gene Ther; 2004 Dec; 11(12):808-18. PubMed ID: 15359290
[TBL] [Abstract][Full Text] [Related]
19. Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice.
Wüest T; Both GW; Prince AM; Hofmann C; Löser P
Vaccine; 2004 Jul; 22(21-22):2717-21. PubMed ID: 15246602
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques.
Takeda A; Igarashi H; Kawada M; Tsukamoto T; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Matano T
Vaccine; 2008 Dec; 26(52):6839-43. PubMed ID: 18930099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]